Home › Funds › Krensavage Asset Management, LLC › SUPN

Krensavage Asset Management, LLC position in SUPN

SUPERNUS PHARMACEUTICALS · Health Care

Krensavage Asset Management, LLC reported holding 280,681 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$13.1M, representing 4.96% of its reported portfolio and ranking #8 among its reported holdings. Krensavage Asset Management, LLC has disclosed SUPN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)280.68K sh
Reported value held$13.05M
Portfolio Weight4.96%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's SUPN position evolved

Krensavage Asset Management, LLC first disclosed a stake in SUPN in Q1 2025 at 431,986 shares (US$14.1M). The position peaked in Q3 2025 at 363,479 shares, worth US$17.4M. Across 6 filings, Krensavage Asset Management, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 280,681 shares valued at US$13.1M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 431.99K $14.15M New
Q2 2025 472.38K $14.89M Add
Q3 2025 363.48K $17.37M Reduce
Q4 2025 313.50K $15.58M Reduce
Q1 2026 280.68K $14.51M Reduce
Q2 2026 280.68K $13.05M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SUPN and 13F data

SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 35 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SUPN

All SUPN fund holders →

FAQ

How long has Krensavage Asset Management, LLC held SUPN?

Krensavage Asset Management, LLC has disclosed SUPN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Krensavage Asset Management, LLC's current position in SUPN?

As of Q2 2026, Krensavage Asset Management, LLC holds 280.68K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $13.05M, representing 4.96% of its reported portfolio and ranking #8.

Has Krensavage Asset Management, LLC been buying or selling SUPN?

In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in SUPN. The position peaked in Q3 2025 at 363.48K shares.

Which other funds hold SUPN?

Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.